Recent CPH News
- Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders • PR Newswire (Canada) • 06/14/2024 04:46:00 PM
- Cipher Pharmaceuticals Reports First Quarter 2024 Results • PR Newswire (Canada) • 05/09/2024 09:00:00 PM
- Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference Call • PR Newswire (Canada) • 05/03/2024 11:05:00 AM
- Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results • PR Newswire (Canada) • 03/14/2024 09:00:00 PM
- Cipher Pharmaceuticals Schedules Q4 2023 Earnings Release and Conference Call • PR Newswire (Canada) • 03/08/2024 12:00:00 PM
- Will Uplisting Be the Catalyst to Send Sharesof this Pharma Company Higher? • AllPennyStocks.com • 01/29/2024 05:56:00 PM
- Will Uplisting Be the Catalyst to Send Shares of this Pharma Company Higher? • AllPennyStocks.com • 01/29/2024 05:56:00 PM
- Cipher Pharmaceuticals Announces the Commencement of OTCQX Trading • PR Newswire (Canada) • 01/29/2024 12:15:00 PM
- Cipher Pharmaceuticals Announces Change of Auditor • PR Newswire (Canada) • 11/24/2023 10:00:00 PM
- Cipher Pharmaceuticals Announces Normal Course Issuer Bid • PR Newswire (Canada) • 11/15/2023 10:00:00 PM
- Cipher Pharmaceuticals Reports Strong Sales & Earnings Growth in Q3 2023 • PR Newswire (Canada) • 11/09/2023 10:00:00 PM
- Cipher Pharmaceuticals Schedules Q3 2023 Earnings Release and Conference Call • PR Newswire (Canada) • 10/27/2023 11:00:00 AM
- Cipher Pharmaceuticals Announces Final Results of Substantial Issuer Bid • PR Newswire (Canada) • 10/12/2023 01:57:00 PM
- Cipher Pharmaceuticals Provides Reminder of the Upcoming Expiration of its Substantial Issuer Bid • PR Newswire (Canada) • 10/03/2023 11:00:00 AM
- Cipher Pharmaceuticals Announces Intention to Commence Substantial Issuer Bid, Aggregate Price up to $6 Million Canadian Dollars • PR Newswire (Canada) • 09/05/2023 11:00:00 AM
- Cipher Pharmaceuticals Releases Q2 2023 Results, Announces Launch of Epuris in Mexico • PR Newswire (Canada) • 08/10/2023 09:00:00 PM
- Cipher Pharmaceuticals Schedules Q2 2023 Earnings Release and Conference Call • PR Newswire (Canada) • 07/28/2023 11:00:00 AM
- Cipher Partner, Moberg Pharma Announces Approval for MOB-015 in the European Union • PR Newswire (Canada) • 07/05/2023 11:00:00 AM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM